Historical record - last NADAC publication: 4/17/2024
Product Information
AMLODIPINE-OLMESARTAN 10-20 MG is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3305 per EA under NDC 68462056790. Its NADAC has been published 222 times since Feb 19, 2020.
The High Outlier badge above means this manufacturer's average price in the Amlodipine and Olmesartan Medoxomil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10; 20 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462056790
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
4/17/2024
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA207807On Market Since
7/5/2017
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has been published 222 times since Feb 19, 2020, and over the history we have for it it has declined 55.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3305 per EA |
|---|---|
| All-time high | $0.8835 (Aug 12, 2020) |
| All-time low | $0.2798 (Nov 17, 2021) |
| Median price | $0.4355 |
| Average price | $0.4666 |
| Largest weekly change | +68.6% (Nov 22, 2023) |
| Weeks tracked | 222 |
| Tracking since | Feb 19, 2020 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 10-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-20 MG, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3305 per EA (NDC 68462056790), effective May 15, 2024.
How has the price of AMLODIPINE-OLMESARTAN 10-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has declined 55.0%. It has been tracked across 222 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-20 MG?
Since Feb 19, 2020, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has ranged from a low of $0.2798 (Nov 17, 2021) to a high of $0.8835 (Aug 12, 2020), with a median of $0.4355 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-20 MG?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, AMLODIPINE-OLMESARTAN 10-20 MG, is $0.2626 per EA — about 21% below AMLODIPINE-OLMESARTAN 10-20 MG.
Who manufactures AMLODIPINE-OLMESARTAN 10-20 MG?
AMLODIPINE-OLMESARTAN 10-20 MG (NDC 68462056790) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification